Verastem
Verastem Oncology is seeking a Senior Director of Translational Research to lead the development and execution of biomarker and pharmacodynamic strategies for clinical programs. This role involves overseeing clinical biomarker activities, managing external vendors, and contributing to preclinical translational studies to inform indication selection and therapeutic combinations. The position requires a highly motivated scientist with strong analytical and cross-functional collaboration skills to advance cancer care.
Headquarters
Needham Heights, Massachusetts, United States
Company Size
51-200 employees
Founded
2010
Verastem Oncology is a biopharmaceutical company focused on developing and delivering novel therapies for RAS/MAPK pathway-driven cancers. The company has advanced the first FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer and maintains a pipeline of small molecule inhibitors targeting KRAS G12D, RAF/MEK, and FAK pathways. Verastem leverages strategic collaborations and ongoing clinical trials to address significant unmet needs across multiple solid tumor types.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Verastem.
Right around the average for this role
Associate Director, Translational Science (Neurology)
Eisai
Translational Biologist
Isomorphic Labs
Translational Scientist
ImmunEdge, Inc
Associated Director Translational Research CVR&H
CSL Behring Australia
Translational Biomarker and CDx Leader
Pierre Fabre Group
Senior Translational Oncologist (Translational Biology), London, Lausanne
Isomorphic Labs